|The Future of Medicine Through Bioengineering - Ayden Jacob|
The Century of the Brain will focus on new diagnostic methods which will help find a precise and accurate diagnose based on varying imaging techniques. In this light, Eli Lilly will begin a new imaging clinical trial to detect the progression of specific plaque in the brains of 3,000 individuals. The goal is to determine which plaque may be causing AD later on in life, and which plaque may be responsible for other types of neurological disorders. Using PET imaging, scientists will have the ability to trace plaque in the brain and correlate its concentration to the symptoms of patient.